Marizyme, Inc. (MRZM)

Marizyme Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.55	0.65	0.23	0.21	0.2	0
Revenue Growth (YoY)	51.66%	176.60%	11.04%	6.67%	-	-
Cost of Revenue	0.58	1.03	0.05	0.08	0.06	0
Gross Profit	-0.03	-0.38	0.18	0.13	0.14	0
Selling, General & Admin	16.56	17.06	8.33	7.23	5.35	0.11
Research & Development	1.89	2.18	3.98	1.68	0.69	0
Other Operating Expenses	10.95	16.96	0.84	0.04	0.59	0.95
Operating Expenses	19.04	19.24	13.15	8.95	5.94	1.06
Operating Income	-19.07	-19.62	-12.97	-8.82	-5.8	-1.06
Interest Income	-1.57	0	2.79	0.13	0.05	0
Interest Expense	32.69	30.22	2.79	0.13	0.05	0
Other Expense / Income	0.5	15.5	25.19	2.18	0.05	1.06
Pretax Income	-69.02	-65.35	-38.17	-11	-5.85	-1.06
Income Tax	15.19	0	24.01	-1.26	0.05	-1.06
Net Income	-69.02	-65.35	-62.18	-9.74	-5.89	-1.06
Shares Outstanding (Basic)	132	45	41	36	26	20
Shares Outstanding (Diluted)	132	45	41	36	26	20
Shares Change	223.36%	11.65%	13.00%	36.66%	33.16%	196.88%
EPS (Basic)	-1.39	-1.44	-1.53	-0.27	-0.22	-0.05
EPS (Diluted)	-1.39	-1.44	-1.53	-0.27	-0.22	-0.05
Free Cash Flow	-4.46	-4.91	-10.85	-5.79	-3.37	-0.13
Free Cash Flow Per Share	-0.03	-0.11	-0.27	-0.16	-0.13	-0.01
Gross Margin	-5.16%	-59.39%	76.74%	61.79%	70.43%	-
Operating Margin	-3469.56%	-3038.56%	-5556.59%	-4195.09%	-2941.93%	-
Profit Margin	-12555.89%	-10118.60%	-26630.27%	-4630.49%	-2988.04%	-
Free Cash Flow Margin	-810.90%	-761.06%	-4647.90%	-2752.10%	-1710.74%	-
EBITDA	-23.87	-18.78	-10.52	-10.16	-5.21	-1.06
EBITDA Margin	-4342.49%	-2908.31%	-4507.08%	-4833.82%	-2641.90%	-
Depreciation & Amortization	0.84	0.84	0.84	0.04	0.59	0
EBIT	-24.71	-19.62	-11.36	-10.21	-5.8	-
EBIT Margin	-4495.33%	-3038.56%	-4867.46%	-4854.68%	-2941.93%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.